Summary Clinical studies highlight that GLP-1RA to treat obesity, alongside their concomitant cardioprotective effects, have become a hallmark in clinical science
Another study in 14 stone-forming individuals without hyperoxaluria administered a probiotic supplementthree times per day after meals, for two weeks, along with a high-oxalate diet
Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint
The amount of copper in a microinfusion session is orders of magnitude below systemic concern
No fillers, no compromise Our Take UnTapped built their reputation on maple gels and waffles with ingredient lists you can actually read
Wegovy injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU NovoNordisk The European Medicines Agency (EMA) has approved an update to the product information for Wegovy injection that allows the medicine to stay at a controlled temperature of up to 30C for up to 48 hours during delivery, reducing distribution complexity for pharmacies and online partners